Given the “oncogenic” nature of these functions, it is not unexpected that up-regulation of YB-1 has been reported in virtually all human cancer types, including epithelial and mesenchymal solid cancers7–16 as well as haematological diseases like lymphoma and leukaemia17, 18. This evidence concerns the gene YBX1 and cancer.